SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Neos Therapeutics Q1 EPS $(0.160) Misses $(0.090) Estimate, Sales $14.493M Miss $14.550M Estimate

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.160) per share which missed the analyst consensus estimate of $(0.090) by 77.78 percent. This is a 6.67 percent decrease over losses of $(0.150) per share

Benzinga · 05/11/2020 20:05

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.160) per share which missed the analyst consensus estimate of $(0.090) by 77.78 percent. This is a 6.67 percent decrease over losses of $(0.150) per share from the same period last year. The company reported quarterly sales of $14.493 million which missed the analyst consensus estimate of $14.550 million by 0.39 percent. This is a 0.96 percent decrease over sales of $14.634 million the same period last year.